DAV protocol
(AREQOOJFWLTHMA-GLRORZIUSA-N)
Structure
- SMILES
- CN(/N=N/c1nc[nH]c1C(=O)N)C.O=CN1c2c(OC)c(ccc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC.ClCCN(C(=O)NCc1cnc(nc1N)C)N=O
- Molecular Formula:
- C61H79ClN16O13
- Molecular Weight:
- 1279.830
- Log P:
- 6.6345
- Hydrogen Bond Acceptor:
- 27
- Hydrogen Bond Donor:
- 7
- TPSA:
- 384.47
- CAS Number(s):
- N/A
Synonym(s)
1.
DAV protocol
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Anus Neoplasms | 12397731 | CTD | |
| 2 | Burkitt Lymphoma | 1457577 | CTD | |
| 3 | Cerebellar Diseases | 8634416 | CTD | |
| 4 | Leukopenia | 8634416 | CTD | |
| 5 | Nausea | 8634416 | CTD | |
| 6 | Thrombocytopenia | 8634416 | CTD | |
| 7 | Vomiting | 8634416 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.